Genetic variation in VTCN1 (B7-H4) is associated with course of disease in juvenile idiopathic arthritis

Annals of the Rheumatic Diseases

Volumn 73, Issue 6, 2014, Pages 1198-1201

  Albers, H M ^a   Reinards, T H C M ^a   Brinkman, D M C ^b   Kamphuis, S S M ^c   Van Rossum, M A J ^d   Hoppenreijs, E P A H ^e   Girschick, H J ^f   Wouters, C ^g   Saurenmann, R K ^h   Bakker, E ^a   Verduijn, W ^a   Slagboom, P ^a   Huizinga, T W J ^a   Toes, R E M ^a   Houwing Duistermaat, J J ^a   Ten Cate, R ^a   Schilham, M W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RIJNLAND HOSPITAL   (Netherlands)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^d EMMA CHILDREN S HOSPITAL   (Netherlands)

^e SINT MAARTENSKLINIEK   (Netherlands)

^f Vivantes Children's Hospital   (Germany)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^h UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CORTICOSTEROID; CYCLIN DEPENDENT KINASE 6; ETANERCEPT; METHOTREXATE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; V SET DOMAIN CONTAINING T CELL ACTIVATION INHIBITOR 1;

ADOLESCENT; ARTHRITIS; ARTICLE; CAUCASIAN; CHILD; COHORT ANALYSIS; DISEASE COURSE; FEMALE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC PARAMETERS; GENETIC VARIABILITY; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLYARTHRITIS; PRIORITY JOURNAL; REMISSION; SINGLE NUCLEOTIDE POLYMORPHISM;

ARTHRITIS; DISEASE ACTIVITY; GENE POLYMORPHISM; JUVENILE IDIOPATHIC ARTHRITIS; T CELLS;

ADOLESCENT; ARTHRITIS, JUVENILE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYCLIN-DEPENDENT KINASE 6; DISEASE PROGRESSION; FEMALE; HUMANS; INFANT; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; V-SET DOMAIN-CONTAINING T-CELL ACTIVATION INHIBITOR 1;

EID: 84899934396     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204466     Document Type: Article

References (20)

1. Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet 2011;377: 2138-49.
2. Bertilsson L, Andersson-Gare B, Fasth A, et al. Disease course, outcome, and predictors of outcome in a population-based juvenile chronic arthritis cohort followed for 17 years. J Rheumatol 2013;40: 715-24.
3. Shenoi S, Wallace CA. Remission in juvenile idiopathic arthritis: current facts. Curr Rheumatol Rep 2010;12: 80-6.
4. Nordal E, Zak M, Aalto K, et al. Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum 2011;63: 2809-18.
5. Wallace CA, Huang B, Bandeira M, et al. Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum 2005;52: 3554-62. (Pubitemid 41612224)
6. Albers HM, Brinkman DM, Kamphuis SS, et al. Clinical course and prognostic value of disease activity in the first two years in different subtypes of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2010;62: 204-12.
7. Oen K, Reed M, Malleson PN, et al. Radiologic outcome and its relationship to functional disability in juvenile rheumatoid arthritis. J Rheumatol 2003;30: 832-40. (Pubitemid 36402781)
8. Ravelli A, Martini A. Early predictors of outcome in juvenile idiopathic arthritis. Clin Exp Rheumatol 2003;21:S89-93. (Pubitemid 37265595)
9. Prahalad S, Glass DN. A comprehensive review of the genetics of juvenile idiopathic arthritis. Pediatr Rheumatol Online J 2008;6:11.
10. Angeles-Han S, Prahalad S. The genetics of juvenile idiopathic arthritis: what is new in 2010? Curr Rheumatol Rep 2010;12: 87-93.
11. Hinks A, Cobb J, Marion MC, et al. Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nat Genet 2013;45: 664-9.
12. Wallace CA, Giannini EH, Huang B, et al. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2011;63: 929-36.
13. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21: 263-5. (Pubitemid 40202029)
14. Sica GL, Choi IH, Zhu G, et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 2003;18: 849-61. (Pubitemid 36776432)
15. Prasad DV, Richards S, Mai XM, et al. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 2003;18: 863-73. (Pubitemid 36776433)
16. Flies DB, Chen L. The new B7s: playing a pivotal role in tumor immunity. J Immunother 2007;30: 251-60. (Pubitemid 46586641)
17. He C, Qiao H, Jiang H, et al. The inhibitory role of B7-H4 in antitumor immunity: association with cancer progression and survival. Clin Dev Immunol 2011;2011:695834.
18. Azuma T, Zhu G, Xu H, et al. Potential role of decoy B7-H4 in the pathogenesis of rheumatoid arthritis: a mouse model informed by clinical data. PLoS Med 2009;6: e1000166.
19. Podojil JR, Liu LN, Marshall SA, et al. B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10/Treg-dependent mechanisms. J Autoimmun 2013;44: 71-81.
20. Albers HM, Kurreeman FA, Stoeken-Rijsbergen G, et al. Association of the autoimmunity locus 4q27 with juvenile idiopathic arthritis. Arthritis Rheum 2009;60: 901-4.